Studies of anticancer drug cytotoxicity based on long‐term HepG2 spheroid culture in a microfluidic system. Issue 8 (14th February 2017)

• Record Type: Journal Article
• Authors: Zuchowska, Agnieszka; Kwapiszewska, Karina; Chudy, Michal; Dybko, Artur; Brzozka, Zbigniew
• Is Part Of: Electrophoresis. Volume 38:Issue 8(2017)
• Page Start: 1206
• Page End: 1216
• Publication Date: 2017-02-14
• Subjects: Anticancer drugs -- Microfluidics -- Spheroid -- Three‐dimensional cell culture -- Tumor model; Electrophoresis -- Periodicals; Electrophoresis -- Periodicals; 541.372
• DOI: 10.1002/elps.201600417
• Languages: English
• ISSNs: 0173-0835

Abstract

Abstract : Cell‐on‐a‐chip systems have become promising devices to study the effectiveness of new anticancer drugs recently. Several microdevices for liver cancer culture and evaluation of the drug cytotoxicity have been reported. However, there are still no proven reports about high‐throughput and simple methods for the evaluation of drug cytotoxicity on liver cancer cells. The paper presents the results of the effects of the anticancer drug (5‐fluorouracil, 5‐FU) on the HepG2 spheroids as a model of liver cancer. The experiments were based on the long‐term 3D spheroid culture in the microfluidic system and monitoring of the effect of 5‐FU at two selected concentrations (0.5 mM and 1.0 mM). Our investigations have shown that the initial size of the spheroids has influence on the drug effect. With the increase of the spheroids diameter, the drug resistance (for the two tested 5‐FU concentrations) decreases. This phenomenon was observed both through cells metabolism analysis, as well as changes in spheroids sizes. In our research, we have shown that the lower 5‐FU (0.5 mM) concentration causes higher decrease in HepG2 spheroids viability. Moreover, due to the microsystem construction, we observe the drug resistance effect (10th day of culture) regardless of the initial size of the created spheroids and the drug concentration.